http://orcid.org/0000-0001-5568-5420
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lu Yao, Yuqing Chen, Xingbo Wang, Zhenwei Bi, Qian Xiao, Jing Lei, Yan Yan, Jiyong Zhou & Liping Yan. (2020) Identification of antigenic epitopes in the haemagglutinin protein of H7 avian influenza virus. Avian Pathology 49:1, pages 62-73.
Read now
Read now
Fan Yang, Yixin Xiao, Rufeng Lu, Bin Chen, Fumin Liu, Liyan Wang, Hangping Yao, Nanping Wu & Haibo Wu. (2020) Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus. Emerging Microbes & Infections 9:1, pages 664-675.
Read now
Read now
Fatima Amanat, Philip Meade, Shirin Strohmeier & Florian Krammer. (2019) Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model. Emerging Microbes & Infections 8:1, pages 155-168.
Read now
Read now
Articles from other publishers (18)
Eduard Puente-Massaguer, Kirill Vasilev, Annika Beyer, Madhumathi Loganathan, Benjamin Francis, Michael J. Scherm, Guha Asthagiri Arunkumar, Irene González-Domínguez, Xueyong Zhu, Ian A. Wilson, Lynda Coughlan, Weina Sun, Peter Palese & Florian Krammer. (2023) Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice. Science Advances 9:37.
Crossref
Crossref
Lena Hansen, Meagan McMahon, Hannah L. Turner, Xueyong Zhu, Jackson S. Turner, Gabriel Ozorowski, Daniel Stadlbauer, Juha Vahokoski, Aaron J. Schmitz, Amena A. Rizk, Wafaa B. Alsoussi, Shirin Strohmeier, Wenli Yu, José Alberto Choreño-Parra, Luis Jiménez-Alvarez, Alfredo Cruz-Lagunas, Joaquín Zúñiga, Philip A. Mudd, Rebecca J. Cox, Ian A. Wilson, Andrew B. Ward, Ali H. Ellebedy & Florian Krammer. (2023) Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo. Immunity 56:8, pages 1927-1938.e8.
Crossref
Crossref
Tazio Vanni, Beatriz C. Thomé, Erin Sparrow, Martin Friede, Christopher B. Fox, Anna Marie Beckmann, Chuong Huynh, Gabriella Mondini, Daniela H. Silveira, Juliana Y. K. Viscondi, Patrícia Emilia Braga, Anderson da Silva, Maria da Graça Salomão, Roberta O. Piorelli, Joane P. Santos, Vera Lúcia Gattás, Maria Beatriz B. Lucchesi, Mayra M. M. de Oliveira, Marcelo E. Koike, Esper G. Kallas, Lucia M. A. Campos, Eduardo B. Coelho, Marilda A. M. Siqueira, Cristiana C. Garcia, Milene Dias Miranda, Terezinha M. Paiva, Maria do Carmo S. T. Timenetsky, Eduardo A. Adami, Milena A. Akamatsu, Paulo Lee Ho & Alexander R. Precioso. (2022) Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial. PLOS ONE 17:10, pages e0274943.
Crossref
Crossref
Wentao Shen, Qian Wang, Zhengxiang Wang, Minxuan Liu, Yingying Du, Lvfeng Yuan, Lu Han, Krzysztof Smietanka, Hualan Chen, Shuai Xu & Qiyun Zhu. (2022) Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication. Journal of Virology 96:18.
Crossref
Crossref
Cong-cong WANG, Si-wen WANG, Ying ZHANG, Jian-zhong SHI, Xin YIN, Cheng-jun LI & Xiu-rong WANG. (2022) Development of a cELISA for effective detection of the antibody against H7 subtype of avian influenza virus. Journal of Integrative Agriculture 21:1, pages 199-207.
Crossref
Crossref
Iuliia M. Gilchuk, Sandhya Bangaru, Nurgun Kose, Robin G. Bombardi, Andrew Trivette, Sheng Li, Hannah L. Turner, Robert H. Carnahan, Andrew B. Ward & James E. CroweJr.Jr.. (2021) Human antibody recognition of H7N9 influenza virus HA following natural infection. JCI Insight 6:19.
Crossref
Crossref
Fatima Amanat, Shirin Strohmeier, Wen-Hsin Lee, Sandhya Bangaru, Andrew B. Ward, Lynda Coughlan & Florian Krammer. (2021)
Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect
In Vivo
in a Mouse Model in a Neutralization-Dependent Manner
. mBio 12:4.
Crossref
Crossref
William J. Liu, Haixia Xiao, Lianpan Dai, Di Liu, Jianjun Chen, Xiaopeng Qi, Yuhai Bi, Yi Shi, George F. Gao & Yingxia Liu. (2021) Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic. Frontiers of Medicine 15:4, pages 507-527.
Crossref
Crossref
Daniel Stadlbauer, Leon de Waal, Edith Beaulieu, Shirin Strohmeier, Edwin J. B. Veldhuis Kroeze, Philippe Boutet, Albert D. M. E. Osterhaus, Florian Krammer, Bruce L. Innis, Raffael Nachbagauer, Koert J. Stittelaar & Corey P. Mallett. (2021) AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets. npj Vaccines 6:1.
Crossref
Crossref
Anders Madsen, Ya-Nan Dai, Meagan McMahon, Aaron J. Schmitz, Jackson S. Turner, Jessica Tan, Tingting Lei, Wafaa B. Alsoussi, Shirin Strohmeier, Mostafa Amor, Bassem M. Mohammed, Philip A. Mudd, Viviana Simon, Rebecca J. Cox, Daved H. Fremont, Florian Krammer & Ali H. Ellebedy. (2020) Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective. Immunity 53:4, pages 852-863.e7.
Crossref
Crossref
Cong Chen, Zuliang Liu, Liguo Liu, Jianmin Wang & Qi Jin. (2020) Enhanced Potency of a Broad H7N9-Neutralizing Antibody HNIgGA6 Through Structure-Based Design. Frontiers in Microbiology 11.
Crossref
Crossref
Olga V. Evdokimova, Stanislav V. Afanasiev, Olga A. Antonova, Valentina I. Konopleva, Ilya S. Gorelov, Alla P. Kruglova & Vladimir V. Biryukov. (2020) A study of the main parameters of immunogenicity of Ultrix vaccine. I.P. Pavlov Russian Medical Biological Herald 28:1, pages 21-29.
Crossref
Crossref
Gavriel MullokandovGayathri Vijayakumar, Paul LeonCarole Henry, Patrick C. Wilson, Florian KrammerPeter PaleseBrian D. Brown. (2020) High-complexity extracellular barcoding using a viral hemagglutinin. Proceedings of the National Academy of Sciences 117:6, pages 2767-2769.
Crossref
Crossref
Huijuan Wang, Jianfang Zhou, Dayan Wang, Baoying Huang & Wenjie Tan. (2019) Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses. Science China Life Sciences 63:2, pages 279-289.
Crossref
Crossref
Daniel Stadlbauer, Xueyong Zhu, Meagan McMahon, Jackson S. Turner, Teddy J. Wohlbold, Aaron J. Schmitz, Shirin StrohmeierWenli YuRaffael Nachbagauer, Philip A. Mudd, Ian A. Wilson, Ali H. EllebedyFlorian Krammer. (2019) Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science 366:6464, pages 499-504.
Crossref
Crossref
Shirin Strohmeier, Fatima Amanat & Florian Krammer. (2019) Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin. Pathogens 8:4, pages 199.
Crossref
Crossref
Felix Broecker, Sean T. H. Liu, Nungruthai Suntronwong, Weina Sun, Mark J. Bailey, Raffael Nachbagauer, Florian Krammer & Peter Palese. (2019) A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains. npj Vaccines 4:1.
Crossref
Crossref
Mohammad Amin Behzadi, Kathryn R. Stein, Maria Carolina Bermúdez-González, Viviana Simon, Raffael Nachbagauer & Domenico Tortorella. (2019) An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies. Vaccines 7:2, pages 51.
Crossref
Crossref